# Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients

> **NCT07461233** · NA · NOT_YET_RECRUITING · sponsor: **Tungs' Taichung Metroharbour Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Symbiotic
- Uremic Toxins
- Gut -Microbiota
- Gut Permeability
- Hemodialysis

## Interventions

- **DIETARY_SUPPLEMENT:** Multispecies Synbiotic Supplementation

## Key facts

- **NCT ID:** NCT07461233
- **Lead sponsor:** Tungs' Taichung Metroharbour Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07461233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07461233, "Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07461233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*